Published in
Elsevier, European Urology, 5(73), p. 696-703
DOI: 10.1016/j.eururo.2017.09.022
Links
Tools
Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial
Journal article published in 2018 by
Pernelle Lavaud,
Gwenaëlle Gravis,
Stéphanie Foulon 
,
Florence Joly,
Stéphane Oudard ,
Frank Priou,
Igor Latorzeff,
Loïc Mourey,
Michel Soulié,
Remy Delva,
Ivan Krakowski,
Brigitte Laguerre,
Christine Théodore,
Jean Marc Ferrero,
Philippe Beuzeboc
and other authors.
,
Florence Joly,
Stéphane Oudard ,
Frank Priou,
Igor Latorzeff,
Loïc Mourey,
Michel Soulié,
Remy Delva,
Ivan Krakowski,
Brigitte Laguerre,
Christine Théodore,
Jean Marc Ferrero,
Philippe Beuzeboc
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 